litlas
Log inCreate account

Subba R. Digumarthy

Active 2006–2026

111
Papers
22,689
Citations
57
h-index
103
i10-index

Citations

Citations per year for Subba R. Digumarthy1945: 1 citations1989: 1 citations2001: 1 citations2004: 1 citations2007: 1 citations2008: 34 citations2009: 93 citations2010: 138 citations2011: 202 citations2012: 256 citations2013: 322 citations2014: 271 citations2015: 251 citations2016: 253 citations2017: 303 citations2018: 289 citations2019: 789 citations2020: 915 citations2021: 968 citations2022: 806 citations2023: 638 citations2024: 931 citations2025: 487 citations2026: 22 citations1946–1988: no citations, so these years are not shown1990–2000: no citations, so these years are not shown2002–2003: no citations, so these years are not shown2005–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,857 citing papers, 26.9% of this breakdownChina: 1,594 citing papers, 15% of this breakdownItaly: 548 citing papers, 5.2% of this breakdownUnited Kingdom: 482 citing papers, 4.5% of this breakdownJapan: 481 citing papers, 4.5% of this breakdownGermany: 429 citing papers, 4.1% of this breakdownFrance: 412 citing papers, 3.9% of this breakdownSouth Korea: 391 citing papers, 3.7% of this breakdownSpain: 321 citing papers, 3% of this breakdownCanada: 301 citing papers, 2.8% of this breakdownNetherlands: 250 citing papers, 2.4% of this breakdownAustralia: 237 citing papers, 2.2% of this breakdown
0%26.9%Other 21.8%

Institutions

Fields

  • Medicine72%
  • Biochemistry, Genetics and Molecular Biology18%
  • Engineering5.9%
  • Immunology and Microbiology1.3%
  • Computer Science0.8%
  • Chemistry0.5%
  • Other1.5%

Topics

  • Lung Cancer Treatments and Mutations13.7%
  • Lung Cancer Research Studies6.8%
  • Cancer Genomics and Diagnostics6.4%
  • Lung Cancer Diagnosis and Treatment5.1%
  • Cancer Immunotherapy and Biomarkers4.7%
  • Cancer Cells and Metastasis4.6%
  • Other58.7%

Coauthors

All papers

Open in search
  1. Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

    Authors: Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman - Science Translational Medicine 2011 cited by 3,556

  2. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    Authors: Biagio Ricciuti, Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong, Jianjun Zhang, Michael Tolstorukov, Yvonne Y. Li, Liam F. Spurr, Andrew D. Cherniack, Gonzalo Recondo, Giuseppe Lamberti, Xinan Wang, Deepti Venkatraman, Joao V. Alessi, Victor R. Vaz, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, S. Khosrowjerdi, Subba R. Digumarthy, Hyesun Park, Nuno Vaz, Mizuki Nishino, Lynette M. Sholl, David A. Barbie, Mehmet Altan, John V. Heymach, Ferdinandos Skoulidis, Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 cited by 367

  3. EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis

    Authors: Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson - Clinical Cancer Research 2016 cited by 1,241

  4. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

    Authors: Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou, Lukas Delasos, J. Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V. Aredo, Michael J. Dennis, Turja Chakrabarti, Susan C. Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W. Riess, So Yeon Kim, Sarah B. Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong, Richard Lee, Biagio Ricciuti, Joao V. Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 cited by 181

  5. Isolation of rare circulating tumour cells in cancer patients by microchip technology

    Authors: Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran, Daphne W. Bell, Daniel Irimia, Lindsey Ulkus, Matthew R. Smith, Eunice L. Kwak, Subba R. Digumarthy, Alona Muzikansky, Paula D. Ryan, Ulysses J. Balis, Ronald G. Tompkins, Daniel A. Haber, Mehmet Toner - Nature 2007 cited by 3,556

  6. Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer

    Authors: Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw - Cancer Discovery 2016 cited by 1,144

  7. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

    Authors: Arvind Ravi, Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai, Chip Stewart, Ignaty Leshchiner, Jaegil Kim, Yo Akiyama, Aaron T. Griffin, Natalie I. Vokes, Mustafa Sakhi, Vashine Kamesan, Hira Rizvi, Biagio Ricciuti, Patrick M. Forde, Valsamo Anagnostou, Jonathan W. Riess, Don L. Gibbons, Nathan A. Pennell, Vamsidhar Velcheti, Subba R. Digumarthy, Mari Mino–Kenudson, Andrea Califano, John V. Heymach, Roy S. Herbst, Julie R. Brahmer, Kurt A. Schalper, Victor E. Velculescu, Brian S. Henick, Naiyer A. Rizvi, Pasi A. Jänne, Mark M. Awad, Andrew Chow, Benjamin D. Greenbaum, Marta Łuksza, Alice T. Shaw, Jedd D. Wolchok, Nir Hacohen, Gad Getz, Justin F. Gainor - Nature Genetics 2023 cited by 186

  8. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Authors: Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate - Journal of Clinical Oncology 2009 cited by 1,882

  9. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

    Authors: Esther Aguilar, Biagio Ricciuti, Justin F. Gainor, Kenneth L. Kehl, Sasha Kravets, Suzanne E. Dahlberg, Mizuki Nishino, Lynette M. Sholl, Anika E. Adeni, S. Subegdjo, S. Khosrowjerdi, Rachel Peterson, Subba R. Digumarthy, C. Liu, Jennifer L. Sauter, Hira Rizvi, Kathryn C. Arbour, B.W. Carter, John V. Heymach, Mehmet Altan, Matthew D. Hellmann, Mark M. Awad - Annals of Oncology 2019 cited by 336

  10. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

    Authors: Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo, John T. Le, Meagan Montesion, Rachael Palmer, Nadine S. Jahchan, Joseph Juan, Chengyin Min, Yi Yu, Xuewen Pan, Kathryn C. Arbour, Natalie I. Vokes, Stephanie Schmidt, David Molkentine, Dwight H. Owen, Regan Memmott, Pradnya D. Patil, Melina E. Marmarelis, Mark M. Awad, Joseph C. Murray, Jessica A. Hellyer, Justin F. Gainor, Anastasios Dimou, Christine M. Bestvina, Catherine A. Shu, Jonathan W. Riess, Collin M. Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Matthias Scheffler, Subba R. Digumarthy, Meghan J. Mooradian, Adrian G. Sacher, Sally C. M. Lau, Andreas Saltos, Julia Rotow, Rocio Perez Johnson, Corinne Liu, Tyler F. Stewart, Sarah B. Goldberg, Jonathan Killam, Zenta Walther, Kurt A. Schalper, Kurtis D. Davies, Mark G. Woodcock, Valsamo Anagnostou, Kristen A. Marrone, Patrick M. Forde, Biagio Ricciuti, Deepti Venkatraman, Eliezer M. Van Allen, Amy L. Cummings, Jonathan W. Goldman, Hiram Shaish, Melanie Wain Kier, Sharyn I. Katz, Charu C. Aggarwal, Ying Ni, Joseph T. Azok, Jeremy Segal, Lauren L. Ritterhouse, Joel W. Neal, Ludovic Lacroix, Yasir Y. Elamin, Marcelo V. Negrão, Xiuning Le, Vincent K. Lam, Whitney E. Lewis, Haley N. Kemp, Brett Carter, Jack A. Roth, Stephen G. Swisher, Richard Lee, Teng Zhou, Alissa Poteete, Yifan Kong, Tomohiro Takehara, Alvaro Guimaraes Paula, Edwin R. Parra, Carmen Behrens, Ignacio I. Wistuba, Jianjun Zhang, George R. Blumenschein, Carl M. Gay, Lauren A. Byers, Don L. Gibbons, Anne S. Tsao, J. Jack Lee, Trever G. Bivona, D. Ross Camidge, Jhannelle E Gray, Natasha B. Leighl, Benjamin Levy, Julie R. Brahmer, Marina Chiara Garassino and 31 more - Nature 2024 cited by 155

  11. Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer

    Authors: Joshua K. Sabari, Vamsidhar Velcheti, K. Shimizu, Matthew R. Strickland, Rebecca S. Heist, Mohini Singh, Naema Nayyar, Anita Giobbie‐Hurder, Subba R. Digumarthy, Justin F. Gainor, Anant P. Rajan, Edwin Nieblas‐Bedolla, Aaron C. Burns, Jill Hallin, Peter Olson, James G. Christensen, Sylvia C. Kurz, Priscilla K. Brastianos, Hiroaki Wakimoto - Clinical Cancer Research 2022 cited by 127

  12. Association of Artificial Intelligence–Aided Chest Radiograph Interpretation With Reader Performance and Efficiency

    Authors: Jong Seok Ahn, Shadi Ebrahimian, Shaunagh McDermott, Sang Hyup Lee, Laura Naccarato, John F. Di Capua, Markus Wu, Éric Zhang, Victorine V. Muse, Benjamin F. Miller, Farid Sabzalipour, Bernardo C. Bizzo, Keith J. Dreyer, Parisa Kaviani, Subba R. Digumarthy, Mannudeep K. Kalra - JAMA Network Open 2022 cited by 132

  13. Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

    Authors: Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Victor R. Vaz, Giuseppe Lamberti, Rosa L. Frias, Deepti Venkatraman, Claudia Angela Maria Fulgenzi, Federica Pecci, Gonzalo Recondo, Alessandro Di Federico, Adriana P C Barrichello, Hyesun Park, Mizuki Nishino, Grace M. Hambelton, Jacklynn V. Egger, Marc Ladanyi, Subba R. Digumarthy, Bruce E. Johnson, David C. Christiani, Xihong Lin, Justin F. Gainor, W. Marston Linehan, David J. Pinato, Adam J. Schoenfeld, Mark M. Awad - Journal of Thoracic Oncology 2023 cited by 91

  14. Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

    Authors: Anna F. Farago, Beow Y. Yeap, Marcello Stanzione, Yin P. Hung, Rebecca S. Heist, Judith Marcoux, Jun Zhong, Deepa Rangachari, David A. Barbie, Sarah Phat, David T. Myers, Robert Morris, Marina Kem, Taronish D. Dubash, Elizabeth A. Kennedy, Subba R. Digumarthy, Lecia V. Sequist, Aaron N. Hata, Shyamala Maheswaran, Daniel A. Haber, Michael S. Lawrence, Alice T. Shaw, Mari Mino–Kenudson, Nicholas J. Dyson, Benjamin J. Drapkin - Cancer Discovery 2019 cited by 238

  15. Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion–Positive Lung Cancer

    Authors: Jessica J. Lin, Noura J. Choudhury, Satoshi Yoda, Viola W. Zhu, Ted W. Johnson, Ramin Sakhtemani, Ibiayi Dagogo‐Jack, Subba R. Digumarthy, Charlotte Lee, Andrew Do, Jennifer Peterson, Kylie Prutisto-Chang, Wafa Malik, Harper Hubbeling, Adam Langenbucher, Adam J. Schoenfeld, Christina J. Falcon, Jennifer S. Temel, Lecia V. Sequist, Beow Y. Yeap, Jochen K. Lennerz, Alice T. Shaw, Michael S. Lawrence, Sai‐Hong Ignatius Ou, Aaron N. Hata, Alexander Drilon, Justin F. Gainor - Clinical Cancer Research 2021 cited by 139

  16. Landscape of Acquired Resistance to Osimertinib in EGFR -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion

    Authors: Zofia Piotrowska, Hideko Isozaki, Jochen K. Lennerz, Justin F. Gainor, Inga T. Lennes, Viola W. Zhu, Nicolas Marcoux, Mandeep K. Banwait, Subba R. Digumarthy, Wenjia Su, Satoshi Yoda, Amanda K. Riley, Varuna Nangia, Jessica J. Lin, Rebecca J. Nagy, Richard B. Lanman, Dora Dias‐Santagata, Mari Mino–Kenudson, A. John Iafrate, Rebecca S. Heist, Alice T. Shaw, Erica Evans, Corinne Clifford, Sai‐Hong Ignatius Ou, Beni B. Wolf, Aaron N. Hata, Lecia V. Sequist - Cancer Discovery 2018 cited by 445

  17. An Artificial Intelligence–Based Chest X-ray Model on Human Nodule Detection Accuracy From a Multicenter Study

    Authors: Fatemeh Homayounieh, Subba R. Digumarthy, Shadi Ebrahimian, Johannes Rueckel, Boj Hoppe, Bastian O. Sabel, Sailesh Conjeti, Karsten Ridder, Markus Sistermanns, Lei Wang, Alexander Preuhs, Florin C. Ghesu, Awais Mansoor, Mateen Moghbel, Ariel Botwin, Ramandeep Singh, Samuel Cartmell, John A. Patti, Christian Huemmer, Andreas Fieselmann, Clemens Joerger, Negar Mirshahzadeh, Victorine V. Muse, Mannudeep K. Kalra - JAMA Network Open 2021 cited by 106

  18. Image Quality and Lesion Detection on Deep Learning Reconstruction and Iterative Reconstruction of Submillisievert Chest and Abdominal CT

    Authors: Ramandeep Singh, Subba R. Digumarthy, Victorine V. Muse, Avinash Kambadakone, Michael A. Blake, Azadeh Tabari, Yiemeng Hoi, Naruomi Akino, Erin Angel, Rachna Madan, Mannudeep K. Kalra - American Journal of Roentgenology 2020 cited by 241

  19. MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

    Authors: Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz, Adam Langenbucher, Jessica J. Lin, Marguerite Rooney, Kylie Prutisto-Chang, Audris Oh, Nathaniel A. Adams, Beow Y. Yeap, Emily Chin, Andrew Do, Hetal D. Marble, Sara E. Stevens, Subba R. Digumarthy, Ashish Saxena, Rebecca J. Nagy, Cyril H. Benes, Christopher G. Azzoli, Michael S. Lawrence, Justin F. Gainor, Alice T. Shaw, Aaron N. Hata - Clinical Cancer Research 2020 cited by 194

  20. Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence

    Authors: Stefan Foser, Kenneth Maiese, Subba R. Digumarthy, Joan Anton Puig‐Butillé, Christian Rebhan - Clinical Chemistry 2024 cited by 70

  21. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs

    Authors: Hyunsuk Yoo, Ki Hwan Kim, Ramandeep Singh, Subba R. Digumarthy, Mannudeep K. Kalra - JAMA Network Open 2020 cited by 122

  22. Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1

    Authors: Mark M. Awad, Ryohei Katayama, Michele McTigue, Wei Liu, Ya-Li Deng, Alexei Brooun, Luc Friboulet, Donghui Huang, Matthew D. Falk, Sergei Timofeevski, Keith D. Wilner, Elizabeth L. Lockerman, Tahsin Khan, Sidra Mahmood, Justin F. Gainor, Subba R. Digumarthy, James R. Stone, Mari Mino–Kenudson, James G. Christensen, A. John Iafrate, Jeffrey A. Engelman, Alice T. Shaw - New England Journal of Medicine 2013 cited by 413

  23. Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

    Authors: Kathryn C. Arbour, Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J. Plodkowski, Mustafa Sakhi, Kevin Huang, Subba R. Digumarthy, Michelle S. Ginsberg, Jeffrey Girshman, Mark G. Kris, Gregory J. Riely, Adam Yala, Justin F. Gainor, Regina Barzilay, Matthew D. Hellmann - Cancer Discovery 2020 cited by 68

  24. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells

    Authors: Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian W. Brannigan, Chey V. Collura, Elizabeth K. Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba R. Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber - New England Journal of Medicine 2008 cited by 1,614